Abstract:Muscle wasting is a severe problem in catabolic diseases such as sepsis and cancer, among others. It is related to muscle weakness and this in turn increases morbidity and mortality of the septic patients (Griffiths et al. 1995). The underlying mechanisms thus far are poorly understood and more studies are needed to better elucidate the process of muscle wasting and how it can be prevented. Next to muscle wasting, septic patients also frequently present with hyperglycaemia and insulin resistance. Whether there is a link between muscle wasting and insulin resistance in septic patients is not yet clear. However, several studies have suggested that such a link exists by the improvement of muscle protein balance and function during insulin treatment (Van den Berghe et al. 2001). It is complicated to perform studies in septic patients directly due to logistic as well as ethical complications; in this sense animal models are helpful in identifying potential underlying mechanisms. During the last decade a family of transcription factors has been identified and indicated to be involved in muscle wasting on the one hand and insulin resistance on the other. This family of transcription factors, named Forkhead box-o (FOXO), is activated during caloric restriction and starvation. Activation of FOXO enhances hepatic glucose production, decreases insulin secretion and causes degradation of skeletal muscle protein as well as glycogen stores and stimulates white adipose tissue lipolysis. All these processes serve to maintain substrate availability in times of exogenous energy deprivation. FOXO transcription factors are, however, also active in the insulin resistant state (Accili & Arden, 2004). Intact PI3K/Akt1 signals to FOXO family transcription factors. Upon insulin-mediated activation of Akt, downstream signalling results in phosphorylation and hence inhibition of FOXO. Inactivated FOXOs are released from the nucleus and thus are no longer in contact with its target genes. In this way Akt regulates FOXO related glucose oxidation and muscle mass maintenance. Although FOXOs involvement in the above-mentioned pathways is established, previous in vivo studies of FOXO have focused on its relation either to muscle wasting or to insulin resistance. In the current issue of The Journal of Physiology, Crossland et al. (2008) have examined FOXO signalling in a rodent model for sepsis in relation to both these conditions. In the study by Crossland et al. a 24 h low dose lipopolysaccharide (LPS) infusion performed in rodents lowered the level of phosphorylated FOXO1 and 3 transcription factors both inside the nucleus and in the cytosol, indicating an increased transcriptional activity of FOXOs on its glycolytic and proteolytic target genes in muscle. A decrease in the extensor digitorium longus (EDL) muscle protein: DNA ratio confirmed muscle wasting after LPS induced endotoxaemia. FOXO transcription factors can control muscle wasting by increasing transcription of the MAFbx and MURF1 genes and indeed mRNA levels of these two genes were increased. MAFbx protein levels were also highly increased in the endotoxin treated rats. Taken together this confirms that the model leads to muscle wasting and that this is most likely related to an increased 26s proteasome activity as is also previously shown in septic patients (Klaude et al. 2007). In addition to muscle wasting, an impairment of glucose oxidation was evident. More specifically, decreased pyruvate dehydrogenase complex activity limited conversion of pyruvate into acetyl-CoA, thereby preventing further oxidative degradation of acetyl-CoA in the TCA cycle. Reduced PDC activity resulted in increased tissue lactate levels, indeed reflecting activation of a relatively energy inefficient pathway of glucose degradation. Hence, muscle glycogen was significantly lower in the endotoxaemia group. FOXO seems to control this pathway by increasing the transcription of the pyruvate dehydrogenase kinase 4 (PDK4). PDK4 is responsible for phosphorylating the pyruvate dehydrogenase complex, which in turn decreases its activity. It therefore seems fair to conclude from the study of Crossland et al. that in endotoxaemic conditions FOXO-mediated reduced pyruvate dehydrogenase complex activity in muscle accelerates degradation of muscular carbohydrate stores. Intact insulin signalling controls the activity of the FOXO proteins through phosphorylation by the Akt signalling molecule. Thus during decreased insulin sensitivity a decreased level of phosphorylated Akt leads to an increase in non-phosphorylated FOXO. In the study by Crossland et al. the total Akt content as well as phosphorylated Akt content was decreased in the endotoxaemic rats. In addition an increased immunological response to endotoxaemia was confirmed by increases in the mRNA levels of TNFα and IL-6. The authors propose a model were the Akt signalling pathway is down-regulated by TNFα, leading to decreased phosphorylation of the FOXO proteins and thereby a shift towards an increased transcription of FOXO target genes related to muscle wasting and decreases in glucose oxidation. The study by Crossland et al. (2008) highlights an important signalling pathway that may have an impact on both muscle wasting and deranged glucose metabolism in sepsis. However, whether the findings can be related to hyperglycaemia and insulin resistance in septic patients with apparent muscle wasting remains to be elucidated.

FOXO, the spindle in the net for wasting diseases?

First Order Quantum Phase Transition in the Hybrid Metal-Mott Insulator Transition Metal Dichalcogenide 4Hb-TaS2

Topological phase transition in Dirac fermionic heterostructures

Multiferroicity and Topology in Twisted Transition Metal Dichalcogenides

Coexistence of Electron and Phonon Topology in Conjunction with Quantum Transport Device Modeling

Dirac Fermions and Topological Phases in Magnetic Topological Insulator Films

Inducing Quantum Phase Transitions in Non-Topological Insulators Via Atomic Control of Sub-Structural Elements

Topological multiferroic phases in the extended Kane-Mele-Hubbard Model in the Hofstadter regime

Electrical Manipulation of Topological Phases in Quantum Anomalous Hall Insulator

Electrically Tunable Topological Phase Transition in van der Waals Heterostructures

Electrical Manipulation of Topological Phases in a Quantum Anomalous Hall Insulator

Quantum oscillations from networked topological interfaces in a Weyl semimetal

Quantum Spin Hall Effect and Topological Phase Transition in Two-Dimensional Square Transition Metal Dichalcogenides

Portrait of locally driven quantum phase transition cascades in a molecular monolayer

Electrodynamics of the quantum anomalous Hall state in a magnetically doped topological insulator

A Gate‐Tunable Ambipolar Quantum Phase Transition in a Topological Excitonic Insulator

Competing Magnetic Orderings And Tunable Topological States In Two-Dimensional Hexagonal Organometallic Lattices

Concurrence of Quantum Anomalous Hall and Topological Hall Effects in Magnetic Topological Insulator Sandwich Heterostructures

Electron-phonon coupling induced topological phase transition in an $α$-$T_{3}$ Haldane-Holstein model

Topological quantum phase transitions driven by a displacement field in the twisted MoTe2 bilayers

Quantum Phase Transitions Driven by Sliding in Bilayer MnBi2Te4